> top > docs > PMC:7600245 > spans > 47806-48413 > annotations

PMC:7600245 / 47806-48413 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T212 13-17 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T16 13-17 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T190 262-284 Disease denotes ankylosing spondylitis http://purl.obolibrary.org/obo/MONDO_0005306
T191 273-284 Disease denotes spondylitis http://purl.obolibrary.org/obo/MONDO_0003937
T192 286-294 Disease denotes bursitis http://purl.obolibrary.org/obo/MONDO_0002471
T193 296-339 Disease denotes polyarticular juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0018456
T194 310-339 Disease denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/MONDO_0011429
T195 330-339 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T196 341-355 Disease denotes osteoarthritis http://purl.obolibrary.org/obo/MONDO_0005178
T197 357-377 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T198 368-377 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T199 379-389 Disease denotes tendonitis http://purl.obolibrary.org/obo/MONDO_0004857
T200 414-418 Disease denotes gout http://purl.obolibrary.org/obo/MONDO_0005393
T201 504-512 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T468 79-80 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T469 212-213 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T470 379-389 http://www.ebi.ac.uk/cellline#tendon denotes tendonitis
T471 379-389 http://www.ebi.ac.uk/efo/EFO_0000952 denotes tendonitis
T472 544-545 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T473 563-568 http://purl.obolibrary.org/obo/CLO_0007225 denotes label

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T686 19-27 Chemical denotes naproxen http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476
T688 56-64 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T689 65-70 Chemical denotes NSAID http://purl.obolibrary.org/obo/CHEBI_35475
T690 97-108 Chemical denotes naphthalene http://purl.obolibrary.org/obo/CHEBI_16482
T691 109-120 Chemical denotes acetic acid http://purl.obolibrary.org/obo/CHEBI_15366
T692 116-120 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T693 446-454 Chemical denotes naproxen http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476
T695 563-568 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T39 286-294 Phenotype denotes bursitis http://purl.obolibrary.org/obo/HP_0025232
T40 310-339 Phenotype denotes juvenile idiopathic arthritis http://purl.obolibrary.org/obo/HP_0005681
T41 341-355 Phenotype denotes osteoarthritis http://purl.obolibrary.org/obo/HP_0002758
T42 357-377 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T43 379-389 Phenotype denotes tendonitis http://purl.obolibrary.org/obo/HP_0025230
T44 391-403 Phenotype denotes dysmenorrhea http://purl.obolibrary.org/obo/HP_0100607
T45 404-408 Phenotype denotes pain http://purl.obolibrary.org/obo/HP_0012531
T46 414-418 Phenotype denotes gout http://purl.obolibrary.org/obo/HP_0001997

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T357 0-132 Sentence denotes In the other hand, naproxen is another synthetic, small molecule NSAID that is a derivative of 2-naphthalene-acetic acid (Figure 7).
T358 133-166 Sentence denotes It was first approved by the U.S.
T359 167-429 Sentence denotes FDA in 1976 for oral use in the treatment of a host of painful inflammatory conditions such as ankylosing spondylitis, bursitis, polyarticular juvenile idiopathic arthritis, osteoarthritis, rheumatoid arthritis, tendonitis, dysmenorrhea pain, and gout [148,149].
T360 430-607 Sentence denotes The efficacy of naproxen in the treatment of critically ill, hospitalized COVID-19 patients is being evaluated in a randomized, open label clinical trial (NCT04325633; n = 584).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1485 513-521 Species denotes patients Tax:9606
1486 19-27 Chemical denotes naproxen MESH:D009288
1487 95-108 Chemical denotes 2-naphthalene
1488 109-120 Chemical denotes acetic acid MESH:D019342
1489 446-454 Chemical denotes naproxen MESH:D009288
1490 262-284 Disease denotes ankylosing spondylitis MESH:D013167
1491 286-294 Disease denotes bursitis MESH:D002062
1492 296-339 Disease denotes polyarticular juvenile idiopathic arthritis MESH:D001171
1493 341-355 Disease denotes osteoarthritis MESH:D010003
1494 357-377 Disease denotes rheumatoid arthritis MESH:D001172
1495 379-389 Disease denotes tendonitis MESH:D052256
1496 391-408 Disease denotes dysmenorrhea pain MESH:D004412
1497 414-418 Disease denotes gout MESH:D006073
1498 475-489 Disease denotes critically ill MESH:D016638
1499 504-512 Disease denotes COVID-19 MESH:C000657245